Hepatitis C Virus Treatment Response to Ledipasvir/Sofosbuvir Among Patients Co-Infected with HIV and HCV: Real-world Data in a Black Population

Mostrar otras versiones (1)

BACKGROUND: Treatment of Hepatitis C virus (HCV) infection for patients with Human Immunodeficiency Virus (HIV) has improved with direct acting antivirals (DAAs). However, outcomes among Black persons treated with ledipasvir/sofosbuvir (LDV/SOF) may be inferior to non-Blacks. We assessed responses t...

Descripción completa

Detalles Bibliográficos
Autores principales: Banga, Jaspreet, Nizami, Sobia, Slim, Jihad, Nagarakanti, Sandhya, Portilla, Mario, Swaminathan, Shobha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630883/
http://dx.doi.org/10.1093/ofid/ofx163.1754

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630883/
http://dx.doi.org/10.1093/ofid/ofx163.1754

Ejemplares similares